Operating Income (Loss) in USD of Trevi Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Trevi Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q1 2018 to Q3 2025.
  • Trevi Therapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$13.9M, a 1.21% increase year-over-year.
  • Trevi Therapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$51.4M, a 6.5% decline year-over-year.
  • Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$51.5M, a 51.9% decline from 2023.
  • Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$33.9M, a 13.4% decline from 2022.
  • Trevi Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$29.9M, a 7.91% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Trevi Therapeutics, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$51.4M -$13.9M +$171K +1.21% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$51.5M -$13.7M -$433K -3.26% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$51.1M -$11.5M +$436K +3.66% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$51.5M -$12.2M -$3.31M -37% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 -$48.2M -$14.1M -$5.04M -55.7% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$43.2M -$13.3M -$4.91M -58.5% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$38.3M -$11.9M -$4.34M -57.4% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$33.9M -$8.93M -$2.28M -34.2% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 -$31.6M -$9.05M -$640K -7.62% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$31M -$8.38M -$562K -7.19% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$30.4M -$7.56M -$538K -7.66% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024
Q4 2022 -$29.9M -$6.66M +$1.62M +19.5% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2024
Q3 2022 -$31.5M -$8.41M -$1.46M -21% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$30.1M -$7.82M +$1.35M +14.7% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$31.4M -$7.03M +$1.06M +13.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$32.5M -$8.27M +$920K +10% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$33.4M -$6.95M +$297K +4.1% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$33.7M -$9.17M -$1.75M -23.7% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$31.9M -$8.09M +$550K +6.37% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$32.5M -$9.19M -$2.43M -35.9% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$30.1M -$7.24M +$406K +5.31% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$30.5M -$7.41M +$4K +0.05% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$30.5M -$8.64M -$3.83M -79.5% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$26.6M -$6.77M -$837K -14.1% 01 Oct 2019 31 Dec 2019 10-K 25 Mar 2021
Q3 2019 -$25.8M -$7.65M -$2.69M -54.3% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$23.1M -$7.42M -$3.04M -69.3% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 -$20.1M -$4.81M -$1.67M -53.2% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$18.4M -$5.93M 01 Oct 2018 31 Dec 2018 10-K 16 Mar 2020
Q3 2018 -$4.96M 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$4.38M 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 -$3.14M 01 Jan 2018 31 Mar 2018 10-Q 14 Jun 2019

Trevi Therapeutics, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$51.5M -$17.6M -51.9% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 -$33.9M -$4.02M -13.4% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 -$29.9M +$2.57M +7.91% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024
2021 -$32.5M +$13K +0.04% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$32.5M -$5.84M -21.9% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$26.6M -$8.24M -44.7% 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021
2018 -$18.4M 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.